Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
Clinical trial NCT03303144 · COMPLETED
Trial details
- NCT number
- NCT03303144
- Sponsor
- Rockwell Medical Technologies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2017-12-28
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.